OTC · Biotechnology

Glorywin Entertainment Group, Inc. (GWIN) Stock

$1.01 +0.00% OTC: GWIN Healthcare

Glorywin Entertainment Group, Inc. is working on 3D bioprinting technology research and development, and anti-cancer drug research and development.

Valuation

MetricValue
Price$1.01
Market Cap$359.76M
P/E Ratio-41351.34
P/B Ratio0.00
P/S Ratio0.00
EPS (TTM)$0.00
52-Week High$3.91
52-Week Low$0.15
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE0.00%
ROA0.00%
ROCE0.00%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.00
Current Ratio0.00

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$0$0$0$0$0
Net Profit$0$0$0$0$0
EPS$0.00$0.00$0.00$0.00$0.00
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets—————
Total Liabilities—————
Cash—————
Borrowings$0$0$0$0$0

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow—————
Investing Cash Flow—————
Financing Cash Flow—————
Net Cash Flow—————
Free Cash Flow$0$0$0$0$0

Valuation & Return Ratios

MetricValue
PEG Ratio-413.51
EV / EBITDA-41351.34
FCF Yield0.00%
Quick Ratio0.00
Interest Coverage0.00
Return 1Y501.19%
Return 3Y1385.29%
Return 5Y708.00%

Ownership

Insiders Held159.72%
Institutions Held0.00%
Institutions Float Held0.00%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About Glorywin Entertainment Group, Inc.

Glorywin Entertainment Group, Inc. is working on 3D bioprinting technology research and development, and anti-cancer drug research and development. The company was incorporated in 2010 and is based in Denton, Texas.

Glorywin Entertainment Group, Inc. is headquartered in US.

Glorywin Entertainment Group, Inc. (GWIN) stock trades at $1.01 with a market capitalization of $359.76M. The stock is valued at a price-to-earnings (P/E) ratio of -41351.34, price-to-book of 0.00, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.15 and $3.91, and currently trades 74.2% below its 52-week high.

On profitability, Glorywin Entertainment Group, Inc. generates a return on equity (ROE) of 0.00%, return on capital employed of 0.00%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: www.glorywinentertainment.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides